Mouse IgG1, Clone LO_MG1_2, Rat Mab anti_, HRP

2318 EUR
2781 USD
1923 GBP
known as: Mouse IgG1, Clone LO_MG1_2, Rat Mab anti_, HRP
Catalog number: genta-YM5053P
Product Quantity: 1 ml.
Supplier: Accu

   CAPTCHA Image   Reload Image

Gene target: igg1 clone lo mg1 2 mab

Related genes to: Mouse IgG1, Clone LO_MG1_2, Rat Mab anti_, HRP

Symbol : mg1 NIH gene
LocusTag : MegaChil _gp0001
description : Bro-N domain-containing protein
type of gene : protein-coding
Modification date : 2016-03-29

Related Pathways to: Mouse IgG1, Clone LO_MG1_2, Rat Mab anti_, HRP

Gene about :IgG1
Pathway :Hs Allograft Rejection

Related product to: Mouse IgG1, Clone LO_MG1_2, Rat Mab anti_, HRP

Related Articles about: Mouse IgG1, Clone LO_MG1_2, Rat Mab anti_, HRP

Frequency dependence of the coercive field of 0.71Pb(Mg1/3Nb2/3)O3-0.29PbTiO3 single crystal from 0.01 Hz to 5 MHz.

The frequency dependence of the coercive field Ec in [001]c poled 0.71Pb(Mg1/3Nb2/3)O3-0.29PbTiO3 single crystals was investigated as a function of frequency f from 0.01 Hz to 5 MHz. Ec was found to be proportional to [Formula: see text] as predicted by the Ishibashi and Orihara model, but our results showed two frequency regimes separated at around 1.0 MHz with different β values. This change of switching kinetics may be due to the presence of slower relaxation times for non-180° domain switching and heterogeneous nucleation of polar nanoregions, whose contribution to polarization reversal is frozen out beyond 1.0 MHz, leading to a larger β. - Source :PubMed

Oncolytic Maraba Virus MG1 as a Treatment for Sarcoma.

The poor prognosis of patients with advanced bone and soft-tissue sarcoma has not changed in the past several decades, highlighting the necessity for new therapeutic approaches. Immunotherapies, including oncolytic viral (OV) therapy, have shown great promise in a number of clinical trials for a variety of tumor types. However, the effective application of OV in treating sarcoma still remains to be demonstrated. Although few pre-clinical studies using distinct OVs have been performed and demonstrated therapeutic benefit in sarcoma models, a side-by-side comparison of clinically relevant OV platforms has not been performed. Four clinically relevant OV platforms (Reovirus, Vaccinia virus, Herpes-simplex virus and Rhabdovirus) were screened for their ability to infect and kill human and canine sarcoma cell lines in vitro, and human sarcoma specimens ex vivo. In vivo treatment efficacy was tested in a murine model. The rhabdovirus MG1 demonstrated the highest potency in vitro. Ex vivo, MG1 productively infected more than 80% of human sarcoma tissues tested, and treatment in vivo led to a significant increase in long-lasting cures in sarcoma-bearing mice. Importantly, MG1 treatment induced the generation of memory immune response that provided protection against a subsequent tumor challenge. This study opens the door for the use of MG1-based oncolytic immunotherapy strategies as treatment for sarcoma or as a component of a combined therapy. - Source :PubMed

Strain-Mediated Coexistence of Volatile and Nonvolatile Converse Magnetoelectric Effects in Fe/Pb(Mg1/3Nb2/3)0.7Ti0.3O3 Heterostructure.

Strain-mediated ferromagnetic/ferroelectric (FE) heterostructures have played an important role in multiferroic materials to investigate the electric-field control of magnetism in the past decade, due to their excellent performances, such as room-temperature operation and large magnetoelectric (ME) coupling effect. Because of the different FE-switching-originated strain behaviors and varied interfacial coupling effect, both loop-like (nonvolatile) and butterfly-like (volatile) converse ME effects have been reported. Here, we investigate the electric-field control of magnetism in a multiferroic heterostructure composed of a polycrystalline Fe thin film and a Pb(Mg1/3Nb2/3)0.7Ti0.3O3 single crystal, and the experimental results exhibit complex behaviors, suggesting the coexistence of volatile and nonvolatile converse ME effects. By separating the symmetrical and antisymmetrical parts of the electrical modulation of magnetization, we distinguished the loop-like hysteresis and butterfly-like magnetization changes tuned by electric fields, corresponding to the strain effects related to the FE 109° switching and 71/180° switching, respectively. Further magnetic-field-dependent as well as angular-dependent investigation of the converse ME effect confirmed the strain-mediated magnetism involving competition among the Zeeman energy, magnetocrystalline anisotropy energy, and strain-generated magnetoelastic energy. This study is helpful for understanding the electric-field control of magnetism in multiferroic heterostructures as well as its relevant applications. - Source :PubMed

Depoling and fatigue behavior of Pb(Mg1/3Nb2/3)O3-PbTiO3 single crystal at megahertz frequencies under bipolar electric field.

Bipolar electric field induced degradation in [001]c poled Pb(Mg1/3Nb2/3)O3-0.29PbTiO3 (PMN-0.29PT) single crystals was investigated at megahertz frequencies. The electromechanical coupling factor kt , dielectric constant εr , dielectric loss D, and piezoelectric constant d33 were measured as a function of amplitude, frequency, and number of cycles of the applied electric field. Our results showed that samples degrade rapidly when the field amplitude is larger than a critical value due to the onset of domain switching. We define this critical value as the effective coercive field Ec at high frequencies, which increases drastically with frequency. We also demonstrate an effective counter-depoling method by using a dc bias, which could help the design of high field driven devices based on PMN-PT single crystals and operated at megahertz frequencies. - Source :PubMed

Deterministic Switching of Perpendicular Magnetic Anisotropy by Voltage Control of Spin Reorientation Transition in (Co/Pt)3/Pb(Mg1/3Nb2/3)O3-PbTiO3 Multiferroic Heterostructures.

One of the central challenges in realizing multiferroics-based magnetoelectric memories is to switch perpendicular magnetic anisotropy (PMA) with a control voltage. In this study, we demonstrate electrical flipping of magnetization between the out-of-plane and the in-plane directions in (Co/Pt)3/(011) Pb(Mg1/3Nb2/3)O3-PbTiO3 multiferroic heterostructures through a voltage-controllable spin reorientation transition (SRT). The SRT onset temperature can be dramatically suppressed at least 200 K by applying an electric field, accompanied by a giant electric-field-induced effective magnetic anisotropy field (ΔHeff) up to 1100 Oe at 100 K. In comparison with conventional strain-mediated magnetoelastic coupling that provides a ΔHeff of only 110 Oe, that enormous effective field is mainly related to the interface effect of electric field modification of spin-orbit coupling from Co/Pt interfacial hybridization via strain. Moreover, electric field control of SRT is also achieved at room temperature, resulting in a ΔHeff of nearly 550 Oe. In addition, ferroelastically nonvolatile switching of PMA has been demonstrated in this system. E-field control of PMA and SRT in multiferroic heterostructures not only provides a platform to study strain effect and interfacial effect on magnetic anisotropy of the ultrathin ferromagnetic films but also enables the realization of power efficient PMA magnetoelectric and spintronic devices. - Source :PubMed

Gentaur adresses

Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
Fax 0032 16 50 90 45
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50
Fax 01 43 25 01 60
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531
Fax 020 8445 9411
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
Tel 058 710 33 44
Fax 058 710 33 48
GENTAUR Nederland BV
Kuiper 1
5521 DG Eersel Nederland
Tel 0208-080893
Fax 0497-517897
Piazza Giacomo Matteotti, 6, 24122 Bergamo
Tel 02 36 00 65 93
Fax 02 36 00 65 94
GENTAUR bulgaria
53 Iskar Str. Kokalyane,
Sofia 1191
Tel 0035929830070
Fax 0035929830072
Tel 0911876558
Genprice Inc, Logistics
547 Yurok Circle
San Jose, CA 95123
invoicing/ accounting:
6017 Snell Ave, Suite 357
San Jose, CA. 96123
Tel 001 408 780 0908